Ipca Laboratories reschedules Q2 FY26 earnings call 30 minutes earlier

Ipca Laboratories has announced a preponement of its conference call to discuss Q2 FY26 earnings and business updates. Originally slated for 4:00 pm IST on Thursday, November 13, 2025, the call will now commence 30 minutes earlier at 3:30 pm IST on the same day. This adjustment was communicated on November 12, 2025, following an initial intimation on November 6, 2025.

The conference call will run until 4:30 pm IST and will be hosted by Dam Capital Advisors Ltd. Representing Ipca Laboratories will be a.k. jain, managing director, and harish kamath, corporate counsel & company secretary. Participants can dial in via universal access numbers +91-22-6280 1384 or +91-22-7115 8285, accessible from all networks and countries.

Attendees are advised to dial in 5-10 minutes prior to the revised start time. For additional information, anusha kawthankar of Ipca Laboratories can be reached at +91-22-6210 6051, and nitin agarwal of Dam Capital Advisors Ltd. can be contacted at +91-22-42022568.